International Journal of Radiation Oncology * Biology * Physics
Volume 82, Issue 2 , Pages 739-742, 1 February 2012

Phase I Clinical Trial Assessing Temozolomide and Tamoxifen With Concomitant Radiotherapy for Treatment of High-Grade Glioma

Presented at the 2005 American Society for radiation Oncology Annual Meeting.

  • Shilpen Patel, M.D.

      Affiliations

    • Department of Radiation Oncology, University of Washington, Seattle, WA
    • Corresponding Author InformationReprint requests to: Shilpen Patel, M.D., Department of Radiation Oncology, University of Washington, 1959 Northeast Pacific Street, Box 356043, Seattle, WA 98195-6043. Tel: (206) 598-4100; Fax: (206) 598-3786
    • ,
  • Steven DiBiase, M.D.

      Affiliations

    • Robert Wood Johnson School of Medicine, Camden, NJ
    • ,
  • Barry Meisenberg, M.D.

      Affiliations

    • DeCesaris Cancer Institute, Annapolis, MD
    • ,
  • Todd Flannery, M.D.

      Affiliations

    • Princeton Radiation Oncology, Princeton, NJ
    • ,
  • Ashish Patel, M.D.

      Affiliations

    • Division of Radiation Oncology, Abington Memorial Hospital, Abington, PA
    • ,
  • Anil Dhople, M.D.

      Affiliations

    • MIMA Cancer Center, Melbourne, FL
    • ,
  • Sally Cheston, M.D.

      Affiliations

    • Department of Radiation Oncology, University of Maryland, Baltimore, MD
    • ,
  • Pradip Amin, M.D.

      Affiliations

    • Department of Radiation Oncology, University of Maryland, Baltimore, MD

Received 15 May 2010; received in revised form 22 December 2010; accepted 31 December 2010. published online 28 February 2011.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Conflict of interest: none.

PII: S0360-3016(11)00051-4

doi:10.1016/j.ijrobp.2010.12.053

International Journal of Radiation Oncology * Biology * Physics
Volume 82, Issue 2 , Pages 739-742, 1 February 2012

Article Tools